Prostate Cancer Patient & Caregiver Clinical Trial Educational Event
Are you or a loved one battling metastatic prostate cancer? Join us to learn about MacroGenics TAMARACK & LORIKEET 2 clinical studies. Dr. Ashley Ward will be explaining both trials and answering YOUR questions.
The Prostate Conditions Education Council
Dr. Ward is the Vice President of Clinical Development at MacroGenics, where she leads a team that designs and runs clinical trials that help us understand the safety and efficacy of new biologic drugs for people with cancer. Before joining MacroGenics in 2021, Dr. Ward worked at Foundation Medicine, where she led the clinical development of several comprehensive genomic profiling tests. She also spent five years at the U.S. Food and Drug Administration ensuring the safe conduct of clinical trials and evaluating the evidence supporting the approvals of new drugs, first as a clinical reviewer in the Division of Hematology Products and later as leader of the Melanoma/Sarcoma Team and as acting associate director of the Division of Oncology Products 2. Additionally, she has been a member of the early clinical development group at Genentech, where she led the development teams for several small molecules and antibody-drug conjugates through early-phase testing for hematologic malignancies and breast cancer.
Before shifting her career to focus on drug and diagnostic test development, Dr. Ward conducted laboratory-based research on Ras-driven hematologic malignancies at the University of San Francisco. She received the American Cancer Society’s Individual Research Award in 2013 and the Hyundai Foundation’s Hope on Wheels Scholar Award in 2012. She has published in multiple peer-reviewed journals, including The Annals of Oncology, Blood, and Clinical Cancer Research. Dr. Ward received her B.A. in Biology from Swarthmore College, and her medical degree from Washington University School of Medicine. She completed her residency and chief residency at St. Louis Children’s Hospital and her fellowship in pediatric hematology and oncology at the University of California, San Francisco. She is board-certified in General Pediatrics and Pediatric Hematology/Oncology.